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Abstract: Different strategies have been employed to provide adequate nutrients for engineered
living tissues. These have mainly revolved around providing oxygen to alleviate the effects of
chronic hypoxia or anoxia that result in necrosis or weak neovascularization, leading to failure
of artificial tissue implants and hence poor clinical outcome. While different biomaterials have
been used as oxygen generators for in vitro as well as in vivo applications, certain problems
have hampered their wide application. Among these are the generation and the rate at which
oxygen is produced together with the production of the reaction intermediates in the form
of reactive oxygen species (ROS). Both these factors can be detrimental for cell survival and
can severely affect the outcome of such studies. Here we present calcium peroxide (CPO)
encapsulated in polycaprolactone as oxygen releasing microparticles (OMPs). While CPO releases
oxygen upon hydrolysis, PCL encapsulation ensures that hydrolysis takes place slowly, thereby
sustaining prolonged release of oxygen without the stress the bulk release can endow on the
encapsulated cells. We used gelatin methacryloyl (GelMA) hydrogels containing these OMPs
to stimulate survival and proliferation of encapsulated skeletal myoblasts and optimized the
OMP concentration for sustained oxygen delivery over more than a week. The oxygen releasing
and delivery platform described in this study opens up opportunities for cell-based therapeutic
approaches to treat diseases resulting from ischemic conditions and enhance survival of implants
under severe hypoxic conditions for successful clinical translation.
Keywords: oxygen; sever hypoxia; microparticles; electrospray; hydrogels; cells; biomaterials
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1. Introduction
Higher-level organisms have evolved advanced circulatory systems that provide tis-
sues with nutrients, e.g., glucose and oxygen via blood. Any aberration in this system
can impair the delivery of nutrients and result in starvation-induced cell death, causing
permanent loss of tissue function [1]. This has resulted in an increasing demand to generate
clinical sized vascularized tissue-engineered constructs that can be implanted to alleviate
anoxia induced tissue loss [2]. However, fabricating thick tissues in the lab poses chal-
lenges from the perspective of mass transport and diffusion limitations. A new class of
biomaterials that release oxygen have been proposed and is being investigated to resolve
these issues in lab fabricated tissue-like constructs [1,3]. Oxygen releasing materials aim to
sustain or restore a tissue’s aerobic respiration, which drives carbohydrate metabolism and
all the downstream physiologic functions. These biomaterials have been shown to improve
cell survival under hypoxic conditions where oxygen supply is limited [4]. Maintaining
mild hypoxia under anoxic conditions can promote vascularization and angiogenesis. This
is critical for various regenerative engineering applications, especially tissue formation and
healing processes [5]. Two critical factors that determine the angiogenic effects from any
oxygen releasing material are duration for which oxygen is released and the concentration
that is maintained during its release. Oxygen more than normoxic condition is equally
detrimental as when it is below a certain amount that leads to severe hypoxia [6,7]. As
such, maintaining it within a particular concentration regime over a certain period of time
necessitates its angiogenic and vasculogenic properties. While different biomaterials have
been proposed and studied in the form of thin-films, hydrogen peroxide laden micropar-
ticles, perfluorocarbons, solid peroxides, etc., most of these platforms have offered less
freedom in terms of oxygen release payloads or duration of release, leading to unfavorable
outcomes [8].
Here, we present an engineered system consisting of oxygen releasing microparticles
(OMPs) and explore these to sustain aerobic respiration of artificial tissues over a period of
approximately 2 weeks. Chemical species such as calcium peroxide (CPO)-based oxygen
generation have been exploited sustaining the cells’ metabolic needs under anoxic con-
ditions; however, the unrestrained oxygen generation and release detrimentally affected
the consequent oxygen tensions’ stability [5,9]. In its essence, while oxygen converts nu-
trients into energy; however, as pointed out before, it is highly important to maintain its
concentration and release duration within a specific window. CPO is known for its burst
release [10]. CPO may be able to support oxygen release at rates and durations that are
angiogenic and enhance survival and neovascularization, only if its release is properly
regulated. As the oxygen generation capability of CPO is based on hydrolysis, restricting
water molecules’ availability can control the subsequent oxygen production from CPO
and hence its release duration. Encapsulation of CPO in a hydrophobic polymer has been
shown to extend release times and also lower the toxicity from its ROS that are formed as
by-products during its hydrolysis [11]. Polycaprolactone (PCL) encapsulation results in
controlling hydrolysis of CPO by limiting water access and hence leads to sustained oxygen
release (Figure 1). We studied cell survival of cells encapsulated within OMP containing
gelatin methacryloyl (GelMA) hydrogels under severely hypoxic conditions. The oxygen
generation sustained metabolic activity and proliferation rates of encapsulated cells. We
further tested survival of cells within 3D printed fluidic channels within a Pluronic F-127
(PF-127) made hollow channels as a model of an endothelial vessel.
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Figure 1. (ai) Schematics showing flow chart of the electrospraying (ES) method for synthesis of OMPs, (aii) O𝟐 release 
from OMPs upon hydrolysis, (b) OMPs in GelMA lead to survival and proliferation of cells. 
2.3. Size and Morphology of OMPs 
Figure 1. (ai) Schematics showing flow chart of the electrospraying (ES) method for synthesis of OMPs, (ai ) O2 release
from OMPs upon hydrolysis, (b) OMPs in GelMA lead to survival and proliferation of cells.
2. Materi ls and Methods
2.1. Materials
Polycaprolactone (PCL, 45 kDa), calcium peroxide (CPO, 200 mesh), PF-127, and
polyethylene glycol (PEG400) were obtained from Sigma-Aldrich (St. Louis, MO, USA) and
used as received. Chloroform and dichloromethane (DCM) solvents were also purchased
from Sigma-Aldrich (USA). Gelatin from porcine skin (type-A, 300 bloom), methacrylic
anhydride, 2-hydroxy-4′-(2-hydroxyethoxy)-2-methylpropiophenone (photoinitiator, PI,
Irgacure 2959), Triton X-100, and bovine serum albumin (BSA) were also purchased from
Sigma-Aldrich (USA). Deionized water (DI water) was taken from a Millipore Milli-Q
Reference ultra-pure water purifier (St. Louis, MO, USA). All chemicals were of the
analytic grade and used without further treatment. Sylgard 184 Silicone Elastomer kit was
purchased from Dow Corning Corporation (Midland, MI, USA), and PMMA sheets were
obtained from McMaster-Carr (Elmhurst, IL, USA). Dulbecco’s phosphate-buffered saline
(DPBS), fetal bovine serum (FBS), trypsin-ethylenediaminetetraacetic acid (trypsin-EDTA),
penicillin/streptomycin, 4′,6-diamidino-2-phenylindole (DAPI), Live/Dead Viability Kit,
Alexa Fluor 594- and Alexa Fluor 555-conjugated secondary antibodies were purchased
from Abcam (Cambridge, MA, USA). All other chemicals used in this study were obtained
from Sigma-Aldrich unless otherwise noted.
2.2. Fabrication and Characterization of Oxygen Releasing Microparticles (OMPs)
OMPs were obtained via electrospray (ES) method (Figure 1ai). Briefly, PCL (10% w/v)
and CPO (1% w/v) were dissolved in chloroform by stirring (IKA® RCT essential, San Diego,
CA USA) for at least 3 h at room temperature to create a homogenous solution, which was
subsequently used for the ES process. PEG400 (0.5% w/v) or Pluronic (0.5%) as stabilizer
were prepared in DCM and stirred for 1 h. The working temperature was 18 ± 1 ◦C, and
the relative humidity was controlled in the range of 50–60%. To synthesize OMPs with
different CPO concentrations and different stabilizing agents, polymer solutions containing
10% PCL, with CPO at 0, 0.5, 1, 2, and 5% (w/v):PEG 0.5% and Pluronic 0.5% were used.
The respective solutions were poured in a syringe and allowed to flow through a needle (26
gauge) at a feeding rate of 4.2 mL·h−1 into a metallic stainless-steel needle (inner diameter:
0.8 mm; outer diameter: 1 mm). ES was enabled by applying a controlled electrical field
(Test Equipment, Gainesville, GA, USA, USA) to the processing head (16 kV). Under the
action of an optimized electrical force, fine droplets resulting from the ejected fluid jet
(under cone-jet mode) were collected at a distance of 15 cm on aluminum foil. After the ES
was complete, absolute ethanol was pipetted onto the aluminum foil and sprayed solidified
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particles were collected directly in a 50 mL falcon tube. The solidified OMPs were put in a
desiccator for one week to ensure complete dryness before further characterization. For
microscopy, OMPs obtained directly from the desiccator were used for imaging
2.3. Size and Morphology of OMPs
Size and surface morphology of OMPs were analyzed using Scanning Electron Micro-
scope (SEM). Briefly, dry OMPs were placed on double-sided black carbon tape. Samples
were sputter coated with a 10 nm gold layer under vacuum and examined with SEM (Zeiss
Supra55) at 5 kV accelerating voltage.
2.4. Release Kinetics of Peroxide (H2O2) and Oxygen (O2) from OMPs
Kinetic assay for H2O2 release from the OMPs was carried out by H2O2 Amplex®
Red Assay Kit using a spectrophotometer (571/585 nm) and following the manufacturer’s
protocol. The reaction follows Michaelis–Menten kinetics. Kinetic parameters Km and Vmax
were obtained by linear regression analysis of the double reciprocal Lineweaver–Burk plots.
The turnover number, Km was calculated according to the following equation:
1/V = Km/Vmax[S] + 1/Vmax (1)
where [S] is the final concentration of the released H2O2.
O2 release from OMPs was measured using a commercial oxygen sensor (Unisense;
Denmark). OMPs at different concentrations were put in anoxic phosphate buffered saline
(PBS) and studied for oxygen release every day under a nitrogen gas purged chamber. The
sensor was calibrated with a 2-point calibration for PBS with 0 (N2 gas purged) and 21%
(air saturated) O2 concentrations, respectively.
2.5. GelMA Synthesis
GelMA was prepared according to an established protocol [12]. Briefly, gelatin from
porcine skin was dissolved in PBS for 2 h at 60 ◦C under constant stirring to yield a 10 %
(w/v) gelatin solution. To modify with methacryloyl substitution, a volume corresponding
to 4% (v/v) of methacrylic anhydride was added gradually to the gelatin solution and
subsequently incubated and stirred for 1 h at 60 ◦C and 500 rpm. Two volumes of pre-
warmed (37 ◦C) PBS were then added, and the solution was dialyzed for at least 5 days
against deionized water. After dialysis, the GelMA solution was filtered and freeze-dried.
2.6. Cell Culture
Cells used for the characterization with the microfluidic system were immortalized
skeletal myoblasts, C2C12. The C2C12 cell line was obtained from ATCC® CRL-1772™
(Manassas, VA, USA). Before cell seeding, C2C12 cells were cultured in DMEM cell culture
medium supplemented with 10% FBS and 1% penicillin-streptomycin at 37 ◦C and 5% CO2.
Media was changed every 2–3 days, and once 80% confluency was reached, they were
harvested and used for further steps.
2.7. Microfluidic Channel
Microfluidic perfusion channel was fabricated by casting PDMS around laser cut
PMMA molds. 4 mm thick PMMA layers (8560K239, McMaster) were machine cut using
a laser cutter (Universal Laser Systems, Scottsdale Arizona USA). A bioprinter (BioBots,
Inc. Philadelphia, PA, USA) equipped with a 27G blunt needle was used to create a 3D
sacrificial scaffold from 40% (w/v) PF-127 in water. To create cellularized micro channels,
5% (w/v) GelMA in FBS was mixed with 0.2% (w/v) 2-hydroxy-4′-(2-hydroxyethoxy)-2-
methylpropiophenone. C2C12 cells and OMPs were suspended in this GelMA solution at
a final concentration of 3 × 106 cells mL−1 and 0–10% (w/v) OMPs. Following overnight
dehydration, the printout was placed on top of a mold of 10 mm (length) × 4 mm (width)
× 4 mm (height) size which was then filled with GelMA prepolymer and cured on both
sides under UV (power: 850 mW, OmniCure Series 2000, Heerbrugg, Switzerland). After
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crosslinking of GelMA, the block was placed in cold PBS and left at 4 ◦C for 15 min. The
liquified sacrificial scaffold of PF-127 was then removed using a syringe. Cell-laden and
OMP containing blocks were then placed back inside a tissue culture incubator set at
37 ◦C for subsequent culture. DMEM was perfused within the straight channels of 500 µm
diameter at a continuous flow rate of 20 µL/min for 7 days via a syringe pump (Harvard
Apparatus, Holliston, MA, USA).
2.8. Cell Viability and Morphology Aanalyses
Cell viability was assessed by a LIVE/DEAD staining assay for live (calcein-AM;
Green) and dead (ethidium homodimer-1; Red) cells. Constructs were washed twice with
PBS, followed by incubation for 15 min in the live/dead assay solution in the dark. The
samples were washed again with PBS and immediately imaged using a Zeiss Imager (Zeiss,
Oberkochen, Germany) fluorescent microscope. For proliferation, C2C12 cells were fixed
in a 4% formaldehyde solution in PBS. Alexa-568 phalloidin was used to stain f-actin
(1:100 dilution). C2C12 was stained using Alexa-488 goat anti-mouse secondary antibody
(Invitrogen, 1:200 dilution). Nuclei were counter-stained with DAPI. The staining results
were examined using a fluorescent microscope (Zeiss, Germany).
2.9. Statistical Analysis
Statistical analysis was performed using Prism 7 (GraphPad Software, Northside Dr.,
San Diego, CA, USA). A value of p < 0.05 was defined as statistically significant. One-way
analysis of variance (ANOVA) was used to analyze the (%) cell viability data.
3. Results and Discussion
CPO as a solid peroxide has a capability to release oxygen upon hydrolysis. Figure 1a
shows the schematics of OMP synthesis, O2 release from these particles, and the chemistry
that lies behind this chemical process. Producing microparticles using ES is not new and has
already been employed to synthesize a wide variety of materials. We used this technique
to produce OMPs with CPO as the main oxygen generating source encapsulated in PCL.
Compared to CPO concentrations varying from 0.5 to 5% did not seem to influence the size
of the OMPs as much as was seen with using the surfactants, PEG or PF-127 at 0.5% (v/v).
The reason for this observation might be the change in electrostatic and weak intermolecular
hydrophilic interactions that groups such as PEG and PF-127 affect or induce via their
amphiphilic nature making it possible to increase hydrophilicity of particles encapsulated
in an otherwise hydrophobic polymer, such as PCL (representative images in Figure 2).
Interestingly, these stabilizing groups also affect the way OMPs interact with cells and
thus have been shown to increase cytocompatibility in our particles. Figure 1ai shows
the schematics of the synthesis process and SEM images in Figure 2 show the effect these
stabilizing agents have on the size of the synthesized OMPs. All the different synthesized
particles showed a round shape. According to Montesdeoca et al. [13], indeed porosity and
hence access to water for hydrolysis is affected by the PCL encapsulation together with CPO
concentration and hence contributes to the oxygen release for a longer time. In addition,
it seems that the stabilizing molecules in the form of surfactants that act as capping layer
for these OMPs play a pivotal role in defining the degree of diffusion of the medium,
facilitating the exchange of nutrients and oxygen for the cells. In the samples with PCL 10%
and PF-127 0.5% (Figure 2c.2) there is a slight indication for the production of nanofibers.
This is a further indication the effect these stabilizing groups can have on hydrophobic
polymer, bringing a change in the overall output in the form of the type of species one
can produce—particles or fibers. This result could be associated with selected applied
electrical field and solution parameters during the ES process as previously described from
our group elsewhere [13,14]. Particle size distribution analysis indicated that all samples
have average sizes between 1 and 10 µm. This result is interesting because, as reported
elsewhere, regardless of the concentration of the dopant, difference in electric potential and
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surface viscosity are not affected [15] when prepared under similar synthesis conditions.
Similar to what is observed in our study.




Figure 2. Representative SEM and particle size analysis from OMPs. Controls (without CPO): (a1–
3) PCL 10%, (b) PCL 10%/PEG 0.5% and (c) PCL 10%/Pluronic 0.5%: (d) PCL 10%/CPO 5%, (e) PCL 
10%/CPO 5%/PEG 0.5%, and (f) PCL 10%/CPO 5%/Pluronic 0.5%. Photos showing particles in low 
and high magnification showing distribution and surface morphology of the particles (1 and 2); (3) 
Particle size analysis showing distribution of obtained OMPs. OMPs with only CPO at 5% are pre-
sented as the size did not seem to vary with increased CPO concentration but correlated with the 
stabilizer content. 
Figure 3 shows a clear change in the hydrolysis pattern in presence and absence of 
PCL. Clearly, PCL encapsulation extended H2O2 and O2 release profiles as compared to 
when CPO was directly studied in PBS with unhindered hydrolysis.  
Fig re 2. Represe t ti rti l i l i fr . tr l ( it t ): (a1–3)
PCL 10%, (b) PCL 10%/PEG 0.5% and (c) PCL 10%/Pluronic 0.5%: (d) PCL 10%/CPO 5%, (e) PCL
10%/CPO 5%/PEG 0.5%, and (f) PCL 10%/CPO 5%/Pluronic 0.5%. Photos showing particles in
low and high magnification showing distribution and surface morphology of the particles (1 and 2);
(3) Particle size analysis showing distribution of obtained OMPs. OMPs with only CPO at 5% are
presented as the size did not seem to vary with increased CPO concentration but correlated with the
stabilizer content.
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We engineer and explore OMPs which can sustain aerobic respiration of cells and
possible tissues under severely hypoxic or anoxic conditions. The innovation of oxygen-
generating biomaterials is a promising method in the area of biomaterial-based therapies.
Approaches such as CPO-based oxygen generators showed the capacity to satisfy the
metabolic needs of cells under anoxic conditions; however, their unrestrained oxygen
generation or peroxide release had a negative effect on the equilibrium of the resultant
oxygen tension or peroxide toxicity, respectively [1,16]. We provide controlled oxygen
release that can affect the overall metabolism of the cells. As CPO’s oxygen generation
capability is based on hydrolysis, restricting water availability can control this process
which in turn can be used to tune oxygen release [17]. Encapsulation of CPO in a hy-
drophobic polymer extends release times and also lowers the toxicity of CPO for cells.
Despite yielding promising results, all tested approaches could only generate oxygen for
a short period. Specifically, conventional approaches did not produce a relatively stable
oxygen tension.
Figure 3 shows a clear change in the hydrolysis pattern in presence and absence of
PCL. Clearly, PCL encapsulation extended H2O2 and O2 release profiles as compared to
when CPO was directly studied in PBS with unhindered hydrolysis.




Figure 3. Release kinetics for H2O2 (a,b) and O2 (c,d) from CPO and OMPs, respectively showing 
the effect on hydrolysis, and hence H2O2 and O2 release as a function of PCL encapsulation. 
Sustained oxygen generation over more than a week’s time positively affects meta-
bolic activity and proliferation rates of cells encapsulated within hydrogels to fabricate 
artificial tissues or tissues for implants. Figure 4a shows the basic principle and fabrication 
steps for a microfluidic chip consisting of a hollow vessel and a respective custom-de-
signed PDMS microfluidic device. A PF-127 channel as a sacrificial channel can be dis-
solved to fabricate a hollow space within a GelMA hydrogel containing construct as 
shown in Figure 4b. Media could be flown into the device via these hollow channels 
through the top inlet and leave via the bottom outlet. C2C12 myoblast cells encapsulated 
within the hydrogel (Figure 5a) showed good viability for the different concentrations of 
the OMPs co-encapsulated within these hydrogels together with the cells. CPO encapsu-
lation in the hydrophobic polymer, PCL, extended oxygen release times and lowered the 
toxicity of the CPO (Figure 5b).  
Figure 3. Release kinetics for H2O2 (a,b) and O2 (c,d) from CPO and OMPs, respectively showing
the effect on hydrolysis, and hence H O2 and O2 release as a functi n of PCL encapsulation.
Sustained oxygen generation over more than a week’s time positively affects metabolic
activity and proliferation rates of cells encapsulated within hydrogels to fabricate artificial
tissues or tissues for implants. Figure 4a shows the basic principle and fabrication steps for
a microfluidic chip consisting of a hollow vessel and a respective custom-designed PDMS
microfluidic device. A PF-127 channel as a sacrificial channel can be dissolved to fabricate a
hollow space within a GelMA hydrogel containing construct as shown in Figure 4b. Media
could be flown into the device via these hollow channels through the top inlet and leave
via the bottom outlet. C2C12 myoblast cells encapsulated within the hydrogel (Figure 5a)
showed good viability for the different concentrations of the OMPs co-encapsulated within
these hydrogels together with the cells. CPO encapsulation in the hydrophobic polymer,
PCL, extended oxygen release times and lowered the toxicity of the CPO (Figure 5b).




Figure 4. (a) Schematics of the fabrication of sacrificial vessels inside cellularized hydrogels; (b) Brightfield and fluorescent 
images of the fabricated hollow channel showing the inner diameter of the vessel and the before and after images of the 
vessel post PF-127 dissolution in water. Scale bars in (b) = 500 µm. 
Additionally, our engineering approach for fabricating a hollow vessel by integrating 
microchannel structures within a crosslinked hydrogel. We printed our channels with PF-
127. It is known that PF-127 forms a shear-thinning hydrogel at room temperature and 
due to its thermoreversible behavior can return to a solution phase at a low temperature 
and change into a gel when the temperature is increased [18]. A 40% PF-127 aqueous so-
lution was extruded through a syringe needle. The hydrogel retained its shape, allowing 
for cylindrical channels within a GelMA block. Accordingly, we fabricated GelMA con-
structs containing a series of microchannels with varied diameters to indicate different 
blood vessel cross-sections. Our system showed good perfusion performance for over a 
week using a syringe pump equipped with 3 mL syringes connected to the sample blocks 
at a flow rate of 1 mL h−1. This flow rate was chosen to resemble the physiological condi-
tions. Cell viability was then assessed using live/dead staining, calculated from the ratio 
between the number of cells treated with the OMPs and non-treated cells (control). The 
viability of the cells indicated that OMPs showed less to no cytotoxicity. 
Figure 4. (a) Schematics of the fabrication of sacrificial vessels inside cellularized hydrogels; (b) Brightfield and fluorescent
images of the fabricated hollow channel showing the inner dia eter of the vessel and the before and after images of the
vessel post PF-127 dissolution in water. Scale bars in (b) = 500 µm.
Additionall i eering approach for fabricating a hollow vessel by integrating
microchannel str ct i rosslinked hydrogel. We printed our channels with PF-
127. It is o that PF-127 forms a shear-thinni g hydrogel at room temperature and due
to its thermoreversible behavior can return to a solution phase at a low temperature and
change into a gel when the temperature is increased [18]. A 40% PF-127 aqueous solution
was extruded through a syringe needle. The hydrogel retained its shape, allowing for
cylindrical channels within a GelMA block. Accordingly, we fabricated GelMA constructs
containing a series of microchannels with varied diameters to indicate different blood
vessel cross-sections. Our system showed good perfusion performance for over a week
using a syringe pump equipped with 3 mL syringes connected to the sample blocks at a
flow rate of 1 mL h−1. This flow rate was chosen to resemble the physiological conditions.
Cell viability was then assessed using live/dead staining, calculated from the ratio between
the number of cells treated with the OMPs and non-treated cells (control). The viability of
the cells indicated that OMPs showed less to no cytotoxicity.
Although in ome s s e cell viability decr a ed when the concentration of the
OMPs increased beyond 3% (Figure 5c), we believe this could be because of increased
peroxide concentration or a change in porosity or mechanical properties of the hydrogel
that could have been influenced due to either the peroxide or oxygen release. More studies
need to be done to understand the chemistry behind such an observation. At 3% OMP, cell
viability on day 5 was higher than the other OMP concentrations used. OMPs at higher
concentrations decreased cell viability over more than 5 days of the cell culture. This could
be stemming from hyperoxia or higher ROS production that affects cell growth, viability,
and other cellular functions.
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The effect on morphology and cell proliferation was studied using F-actin/DAPI
staining of the encapsulated cells within OMPs at concentrations of 1–10% for 7 days under
hypoxia (Figure 5c). As expected, no noticeable cell spreading was found on day 1, and all
the cells still maintained a round morphology. Cells gradually spread out initially from
spindle shapes to later long stripe-like forms over a week. This indicates a better microcel-
lular environment pro uced as a combination of OMPs’ oxygenation sustaining cellular
metabolism ver the course of study. The proliferation of the encapsulated cells was also
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clearly noticeable. Further studies are needed to look at the effect such a microenvironment
created by OMPs can have over VEGF production, proliferation or neovascularization that
can in turn affect hydrogel degradation and pave a path for eventual anastomosis in an
animal study. The degradation profiles also showed the bio-printed vascular structures
steadily degraded in the culture medium depending on the incubation period.
4. Conclusions
Oxygen-containing biomaterials with outstanding characteristics and benefits in dif-
ferent fields are attractive. We developed an oxygenating platform which acts as a good
oxygen source to maintain healthy cellular function, including under ischemic conditions.
CPO as a solid peroxide was used as an oxygen source that hydrolyses into oxygen upon
contact with water. With unhindered hydrolysis, CPO exhausts its oxygen releasing capabil-
ity in few days’ time. However, encapsulation within a hydrophobic polymer, such as PCL
cuts water access, decreasing hydrolysis and eventually increasing oxygen release times.
Microencapsulation of CPO in PCL micromaterials thus allows for safely increasing both
CPO payload and oxygen release duration. Such a system can provide oxygen supplies
over a prolonged time and can be used in conditions that are affected by ischemia or low
oxygen tension. Cell survival was tested in hydrogel constructs of GelMA hydrogel in the
presence of OMPs with hollow vessels through which media could be flown in a severely
hypoxic environment. The geometry was chosen to recapitulate physiological conditions. It
is of note that the current study is limited to the use of PCL. However, it is anticipated that
alternative hydrophobic materials can offer similar extended oxygen generation profiles
owing to their ability to modify CPO hydrolysis. In nutshell, our system represents a
platform to engineer self-oxygenation of tissues, which allows for controlling the in vivo
oxygen tension for prolonged periods to enhance the success of implant survival and host
acceptance metabolically. It thus represents a good steppingstone towards the development
of clinically sized tissues for regenerative applications.
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